Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'26
Mar'25
Net Sales
171.97
120.29
Other Operating Income
0.00
0.00
Total Operating income
171.97
120.29
Raw Material Cost
149.31
71.29
Purchase of Finished goods
0.00
0.00
(Increase) / Decrease In Stocks
-44.21
3.30
Employee Cost
5.54
4.88
Power Cost
0.00
0.00
Manufacturing Expenses
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
Other Expenses
13.81
8.61
Total Expenditure (Excl Depreciation)
124.45
88.08
Operating Profit (PBDIT) excl Other Income
47.52
32.21
Other Income
0.26
0.17
Operating Profit (PBDIT)
47.78
32.38
Interest
3.74
3.72
Exceptional Items
0.00
0.00
Gross Profit (PBDT)
44.04
28.66
Depreciation
1.52
1.77
Profit Before Tax
42.51
26.89
Tax
13.42
6.37
Provisions and contingencies
0.00
0.00
Profit After Tax
29.09
20.52
Extraordinary Items
0.00
0.00
Prior Period Expenses
0.00
0.00
Other Adjustments
0.00
0.00
Net Profit
29.09
20.52
Share in Profit of Associates
0.00
0.00
Minority Interest
-0.57
0.00
Other related items
0.00
0.00
Consolidated Net Profit
28.51
20.52
Equity Capital
53.15
39.85
Face Value
10.0
10.0
Reserves
177.08
40.57
Earnings per share (EPS)
0.54
0.51
Diluted Earnings per share
0.61
0.64
Operating Profit Margin (Excl OI)
27.63%
26.78%
Gross Profit Margin
25.61%
23.83%
PAT Margin
16.92%
17.06%
Public Share Holdings (%)
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 46.73%
Standalone Net Profit
YoY Growth in year ended Mar 2026 is 35.53%
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 43.25%
Interest
YoY Growth in year ended Mar 2026 is 16.94%
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2026 has fallen from Mar 2025
Compare Annual Results Of Anlon Healthcare With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
171.97
0
171.97
Other Operating Income
0.00
0.00
0.00
Total Operating income
171.97
0
171.97
Raw Material Cost
149.31
0
149.31
Purchase of Finished goods
0.00
0
0.00
(Increase) / Decrease In Stocks
-44.21
0
-44.21
Employee Cost
5.54
0
5.54
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
13.81
0.00
13.81
Total Expenditure (Excl Depreciation)
124.45
0
124.45
Operating Profit (PBDIT) excl Other Income
47.52
0.00
47.52
Other Income
0.26
0
0.26
Operating Profit (PBDIT)
47.78
0
47.78
Interest
3.74
0
3.74
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
44.04
0
44.04
Depreciation
1.52
0
1.52
Profit Before Tax
42.51
0
42.51
Tax
13.42
0
13.42
Provisions and contingencies
0.00
0
0.00
Profit After Tax
29.09
0
29.09
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
29.09
0
29.09
Share in Profit of Associates
0.00
0
0.00
Minority Interest
-0.57
0
-0.57
Other related items
0.00
0.00
0.00
Consolidated Net Profit
28.51
0
28.51
Equity Capital
53.15
0
53.15
Face Value
10.00
0
0.00
Reserves
177.08
0
177.08
Earnings per share (EPS)
0.54
0
0.54
Diluted Earnings per share
0.61
0
0.61
Operating Profit Margin (Excl OI)
27.63%
0%
0.00
27.63%
Gross Profit Margin
25.61%
0%
0.00
25.61%
PAT Margin
16.92%
0%
0.00
16.92%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 176.50 Cr
in Mar 2026Figures in Cr
Annual - Standalone Net Profit
Standalone Net Profit 27.81 Cr
in Mar 2026Figures in Cr
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 46.14 Cr
in Mar 2026Figures in Cr
Annual - Interest
Interest 4.35 Cr
in Mar 2026Figures in Cr
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 26.14%
in Mar 2026Figures in %






